Megasoft [MEGASOFT] vs Zim Laboratories [ZIMLAB] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Megasoft Ltd. wins in 11 metrics, Zim Laboratories Ltd. wins in 7 metrics, with 0 ties. Megasoft Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Megasoft Ltd. | Zim Laboratories Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 7.91 | 58.59 | Megasoft Ltd. |
| Price-to-Book Ratio | 4.71 | 1.58 | Zim Laboratories Ltd. |
| Debt-to-Equity Ratio | 1.39 | 48.92 | Megasoft Ltd. |
| PEG Ratio | -0.07 | 6.01 | Zim Laboratories Ltd. |
| EV/EBITDA | 8.20 | 15.83 | Megasoft Ltd. |
| Profit Margin (TTM) | 80.76% | 1.85% | Megasoft Ltd. |
| Operating Margin (TTM) | -1,366.82% | 7.16% | Zim Laboratories Ltd. |
| EBITDA Margin (TTM) | N/A | 7.16% | N/A |
| Return on Equity | 64.13% | 4.82% | Megasoft Ltd. |
| Return on Assets (TTM) | 26.26% | 2.58% | Megasoft Ltd. |
| Free Cash Flow (TTM) | $194.75M | $3.57M | Megasoft Ltd. |
| 1-Year Return | 406.26% | 14.23% | Megasoft Ltd. |
| Price-to-Sales Ratio (TTM) | 195.06 | 1.20 | Zim Laboratories Ltd. |
| Enterprise Value | $11.98B | $5.44B | Megasoft Ltd. |
| EV/Revenue Ratio | 7.02 | 1.44 | Zim Laboratories Ltd. |
| Gross Profit Margin (TTM) | 67.21% | 55.28% | Megasoft Ltd. |
| Revenue per Share (TTM) | $23 | $78 | Zim Laboratories Ltd. |
| Earnings per Share (Diluted) | $23.90 | $1.44 | Megasoft Ltd. |
| Beta (Stock Volatility) | 0.94 | 0.47 | Zim Laboratories Ltd. |
Megasoft Ltd. vs Zim Laboratories Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Megasoft Ltd. | 4.73% | 10.55% | 44.16% | 161.67% | 113.81% | 115.74% |
| Zim Laboratories Ltd. | 3.83% | 0.49% | 10.35% | 51.74% | 45.70% | 47.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Megasoft Ltd. | 406.26% | 1,175.68% | 3,858.99% | 4,620.00% | 1,731.82% | 249.37% |
| Zim Laboratories Ltd. | 14.23% | -4.49% | -8.78% | -8.78% | -8.78% | -8.78% |
Performance & Financial Health Analysis: Megasoft Ltd. vs Zim Laboratories Ltd.
| Metric | MEGASOFT | ZIMLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹301.22B | ₹4.52B |
| Market Cap Category | Large cap | Small cap |
| 10 Day Avg. Volume | 98,661 | 93,580 |
| 90 Day Avg. Volume | 157,453 | 90,580 |
| Last Close | ₹435.80 | ₹107.89 |
| 52 Week Range | ₹79.50 - ₹446.00 | ₹59.31 - ₹127.00 |
| % from 52W High | -2.29% | -15.05% |
| All-Time High | ₹446.00 (Jun 01, 2026) | ₹127.00 (Jul 18, 2025) |
| % from All-Time High | -2.29% | -15.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.13% |
| Quarterly Earnings Growth | N/A | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | 0.81% | 0.02% |
| Operating Margin (TTM) | -13.67% | 0.07% |
| Return on Equity (TTM) | 0.64% | 0.05% |
| Debt to Equity (MRQ) | 1.39 | 48.92 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹40.12 | ₹53.27 |
| Cash per Share (MRQ) | ₹18.13 | ₹0.95 |
| Operating Cash Flow (TTM) | ₹-2,034,262,016 | ₹201.64M |
| Levered Free Cash Flow (TTM) | ₹165.06M | ₹121.65M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Megasoft Ltd. vs Zim Laboratories Ltd.
| Metric | MEGASOFT (Apr 11, 2026) | ZIMLAB (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 7.91 | 58.59 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.07 | 6.01 |
| Price to Sales (TTM) | 195.06 | 1.20 |
| Price to Book (MRQ) | 4.71 | 1.58 |
| Market Capitalization | ||
| Market Capitalization | ₹301.22B | ₹4.52B |
| Enterprise Value | ₹11.98B | ₹5.44B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.02 | 1.44 |
| Enterprise to EBITDA | 8.20 | 15.83 |
| Risk & Other Metrics | ||
| Beta | 0.94 | 0.47 |
| Book Value per Share (MRQ) | ₹40.12 | ₹53.27 |
Financial Statements Comparison: Megasoft Ltd. vs Zim Laboratories Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MEGASOFT (2025) | ZIMLAB (2025) |
|---|---|---|
| Revenue/Sales | 0 | 3.63B |
| Cost of Goods Sold | 0 | 1.69B |
| COGS % of Revenue | - | 46.5% |
| Gross Profit | 0 | 1.94B |
| Gross Margin | - | 53.5% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -145.21M | 267.00M |
| Operating Margin | - | 7.4% |
| EBITDA | 311.05M | 498.59M |
| EBITDA Margin | - | 13.7% |
| Pre-Tax Income | 84.47M | 180.09M |
| Pre-Tax Income % of Revenue | - | 5.0% |
| Income Tax | 0 | 58.44M |
| Income Tax % of Revenue | - | 1.6% |
| Net Income (Profit) | -299.37M | 121.65M |
| Profit Margin | - | 3.4% |
Balance Sheet & Liquidity Metrics
| Metric | MEGASOFT (2025) | ZIMLAB (2025) |
|---|---|---|
| Cash & Equivalents | 91.70M | 19.47M |
| Total Current Assets | 560.34M | 2.31B |
| Total Current Assets % of Revenue | - | 63.7% |
| Total Current Liabilities | 683.12M | 1.66B |
| Total Current Liabilities % of Revenue | - | 45.8% |
| Long-Term Debt | 1.30B | 423.71M |
| Long-Term Debt % of Revenue | - | 11.7% |
| Total Shareholders Equity | 1.44B | 2.52B |
| Retained Earnings | 348.54M | 1.69B |
| Retained Earnings % of Revenue | - | 46.6% |
| Property, Plant & Equipment | 2.00B | 139.15M |
Cash Flow Statement Comparison
| Metric | MEGASOFT (2025) | ZIMLAB (2025) |
|---|---|---|
| Operating Cash Flow | -492.05M | 201.64M |
| Operating Cash Flow % of Revenue | - | 5.6% |
| Capital Expenditures | -172.66M | -400.66M |
| Free Cash Flow | 194.75M | 3.57M |
| FCF Margin | - | 0.1% |
| Debt Repayment | N/A | -153.20M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MEGASOFT | ZIMLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 1.76B | 53.55M |
| Float Shares | 20.43M | 17.69M |
| % Held by Insiders | 17.06% | 62.42% |
| % Held by Institutions | 0.00% | 0.00% |
| % Held by Public | 82.94% | 37.58% |
Dividend Analysis & Yield Comparison: Megasoft Ltd. vs Zim Laboratories Ltd.
| Metric | MEGASOFT | ZIMLAB |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |